“…The main advantages noted were that social media data included unexpected or new adverse events [35-43, 49, 51, 53, 54, 57, 60, 64, 67, 71-73, 80, 84, 86-90, 92, 98, 101, 104, 105] (24 studies) and that adverse events could be identified earlier [35, 60, 71, 72, 79, 86-88, 92, 93, 98, 101] (9 studies) in social media as compared to those reported in spontaneous reporting systems [35,71,72,76,79,93] , search query logs from search engines [35], drug safety communications [101] and scientific literature [76,[86][87][88]. In contrast, 3 out of the 60 studies suggested that routine surveillance of social media would not aid in earlier identification of ADE signals [24,50,95] , while one stated it will not be useful to confirm previously identified safety signals [45] and another one that certain social media platforms (such as online health forums) may be timelier in signal detection while others (Twitter) will not [35].…”